Project mid-size biotech company located in Mechelen

Posted on 03 November 2019

Share this newsmessage
Project mid-size biotech company located in Mechelen

This clinical-stage biotech company focuses on the discovery and advancement of small molecule drugs with novel mechanisms of action. Their goal is to become a leading global biopharmaceutical company focusing on discovering, developing, and commercializing breakthrough medicines that will enhance people's lives.

For the next year, I will join a team as a senior clinical project leader to support a large phase 3 study for idiopathic pulmonary fibrosis